Sign in
4

Changes in Ownership

Zymeworks Inc. Filed Acc 0000950170-24-003076

Chief Scientific Officer sold 9,799 shares at an average $10.79 ($105,699)

  • Chief Scientific Officer acquired 17,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moore Paul Andrew · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-05 Exercise or conversion : show line 1 in the form +17,166 17,166 D
2024-01-05 Sale : show line 2 in the form −7,460 $10.65 $79,465 9,706 D
2024-01-08 Sale : show line 3 in the form −2,339 $11.22 $26,233 7,367 D
Open-market sales · 9,799 sh · avg $10.79 · $105,699

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-01-05 Exercise or conversion : show line 4 in the form Restricted Stock Unit −17,166 34,334 D
2024-01-05 Grant or award : show line 5 in the form Stock Option (Right to Buy) +90,000 90,000 D
2024-01-05 Grant or award : show line 6 in the form Restricted Stock Unit +60,000 60,000 D
Loading xslF345X05/ownership.xml…